Silence Therapeutics Plc (SLN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 2,786 | 3,235 | 8,026 | 3,815 | 876 |
| Operating Expenses | 13,335 | 14,751 | 19,199 | 12,135 | 7,679 |
| Operating Income | -10,549 | -11,516 | -11,173 | -8,321 | -6,804 |
| Interest Expense | N/A | N/A | N/A | 2 | 2 |
| Other Income | -1,591 | 628 | 773 | 603 | 551 |
| Pre-tax Income | -12,140 | -10,888 | -10,400 | -7,719 | -6,255 |
| Income Tax | -60 | N/A | -270 | -223 | -86 |
| Net Income Continuous | -12,081 | -10,888 | -10,130 | -7,496 | -6,169 |
| Net Income | $-12,081 | $-10,888 | $-10,130 | $-7,496 | $-6,169 |
| EPS Basic Total Ops | -2.49 | -2.76 | -1.96 | -1.78 | -2.62 |
| EPS Basic Continuous Ops | -2.49 | -2.76 | -1.96 | -1.78 | -2.62 |
| EPS Diluted Total Ops | -2.49 | -2.76 | -1.96 | -1.78 | -2.62 |
| EPS Diluted Continuous Ops | -2.49 | -2.76 | -1.96 | -1.78 | -2.62 |
| EBITDA(a) | $-9,949 | $-10,897 | $-10,542 | $-7,026 | $-5,881 |